The Rare/Neglected Disease Track will focus on the issues important to all stakeholders (patients, patient advocates and advocate
organizations, researchers, drug and device companies, investors, clinical thought leaders and governmental agencies), particularly
as they relate to public policy, research and regulation, and special challenges.

At the conclusion of this meeting, participants should be able to:
• Discuss key initiatives, development and strategies involving rare diseases, special populations and orphan drugs

**Please note workshops that were made available during the Annual Meeting included attendee interactivity. Due to such format, audio recordings may not be available.